| Financier | Commitments |
|---|---|
| IDA Credit | 521.00 |
India: National Vector Borne Disease Control & Polio Eradication Support Project
Abstract*
The development objective of the National Vector Borne Disease Control and Polio Eradication Support Project for India is to enhance the effectiveness of government response to control malaria, eliminate kala azar, and eradicate polio. This will be achieved by an increase in the number of people benefiting from effective prevention, diagnosis and treatment of malaria and kala azar, and vaccination against polio. There are four components to the project... Show More
Development Objective
The Project Development Objective (PDO) is to enhance the effectiveness of government response to control malaria, eliminate kala azar and eradicate polio. This will be achieved by an increase in the number of people benefiting from effective prevention, diagnosis and treatment services for malaria and kala azar, and vaccination against polio.
Key Details
Project Details
P094360
Closed
Ramesh Govindaraj
N/A
July 19, 2005
(as of board presentation)
July 31, 2008
March 6, 2009
US$ 521.00 million
N/A
2009
US$ 521.00 million
B
January 15, 2013
December 31, 2013
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 521.00 |
| IBRD + IDA Commitment | 521.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 521.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Jul 15, 2021 | IDA-44610 | Int Charges | 47,531.71 |
| Jul 31, 2008 | IDA-44610 | Loan Commitment | 521,000,000.00 |
| Jul 15, 2024 | IDA-44610 | Int Charges | 39,990.62 |
| Jul 15, 2024 | IDA-44610 | Int Charges | 39,990.62 |
| Jul 15, 2024 | IDA-44610 | Loan Repay | 6,875,587.00 |
| Jul 15, 2024 | IDA-44610 | Loan Repay | 3,175,711.20 |
| Jul 15, 2024 | IDA-44610 | Int Charges | 383,429.06 |
| Jul 15, 2024 | IDA-44610 | Int Charges | 383,429.06 |
| Jan 15, 2024 | IDA-44610 | Int Charges | 49,406.17 |
| Jan 15, 2024 | IDA-44610 | Int Charges | 49,406.17 |
| Jan 15, 2024 | IDA-44610 | Loan Repay | 5,058,932.50 |
| Jan 15, 2024 | IDA-44610 | Int Charges | 396,077.44 |
| Jan 15, 2024 | IDA-44610 | Int Charges | 396,077.44 |
| Jul 15, 2023 | IDA-44610 | Int Charges | 134,956.98 |
| Jul 15, 2023 | IDA-44610 | Int Charges | 134,956.98 |
| Jul 15, 2023 | IDA-44610 | Loan Repay | 5,128,831.00 |
| Jul 15, 2023 | IDA-44610 | Int Charges | 411,506.03 |
| Jul 15, 2023 | IDA-44610 | Int Charges | 411,506.03 |
| Jan 15, 2023 | IDA-44610 | Loan Repay | 89,283.35 |
| Jan 15, 2023 | IDA-44610 | Loan Repay | 5,016,450.00 |
| Jan 15, 2023 | IDA-44610 | Int Charges | 344,313.30 |
| Jan 15, 2023 | IDA-44610 | Int Charges | 344,313.30 |
| Jan 15, 2019 | IDA-44610 | Loan Repay | 5,170,538.50 |
| Jan 15, 2019 | IDA-44610 | Int Charges | 556,496.30 |
| Jan 15, 2019 | IDA-44610 | Int Charges | 556,496.30 |
| Jan 15, 2019 | IDA-44610 | Loan Repay | 112,818.98 |
| Jul 15, 2018 | IDA-44610 | Int Charges | 637,033.60 |
| Jul 15, 2018 | IDA-44610 | Int Charges | 637,033.60 |
| Jul 15, 2018 | IDA-44610 | Int Charges | 84,513.01 |
| Jul 15, 2018 | IDA-44610 | Int Charges | 84,513.01 |
| Jul 15, 2018 | IDA-44610 | Loan Repay | 5,308,613.00 |
| Jan 15, 2018 | IDA-44610 | Int Charges | 88,477.78 |
| Jan 15, 2018 | IDA-44610 | Loan Repay | 5,425,843.00 |
| Jan 15, 2018 | IDA-44610 | Int Charges | 585,068.75 |
| Jan 15, 2018 | IDA-44610 | Int Charges | 585,068.75 |
| Jan 15, 2018 | IDA-44610 | Int Charges | 88,477.78 |
| Jan 15, 2021 | IDA-44610 | Int Charges | 74,225.90 |
| Jan 15, 2021 | IDA-44610 | Int Charges | 74,225.90 |
| Jan 15, 2021 | IDA-44610 | Loan Repay | 2,727,026.00 |
| Jan 15, 2021 | IDA-44610 | Int Charges | 514,389.56 |
| Jan 15, 2021 | IDA-44610 | Int Charges | 514,389.56 |
| Jul 15, 2020 | IDA-44610 | Int Charges | 29,418.12 |
| Jul 15, 2020 | IDA-44610 | Int Charges | 29,418.12 |
| Jul 15, 2020 | IDA-44610 | Loan Repay | 2,632,326.00 |
| Jul 15, 2020 | IDA-44610 | Int Charges | 481,140.22 |
| Jul 15, 2020 | IDA-44610 | Int Charges | 481,140.22 |
| Jan 15, 2020 | IDA-44610 | Int Charges | 10,227.40 |
| Jan 15, 2020 | IDA-44610 | Int Charges | 10,227.40 |
| Jan 15, 2020 | IDA-44610 | Loan Repay | 5,230,876.50 |
| Jan 15, 2020 | IDA-44610 | Int Charges | 539,628.44 |
| Jan 15, 2020 | IDA-44610 | Int Charges | 539,628.44 |
| Jul 15, 2019 | IDA-44610 | Int Charges | 57,256.49 |
| Jul 15, 2019 | IDA-44610 | Int Charges | 57,256.49 |
| Jul 15, 2019 | IDA-44610 | Loan Repay | 5,243,296.50 |
| Jul 15, 2019 | IDA-44610 | Int Charges | 579,619.10 |
| Jan 15, 2022 | IDA-44610 | Loan Repay | 2,632,878.50 |
| Jan 15, 2022 | IDA-44610 | Int Charges | 523,026.80 |
| Jan 15, 2022 | IDA-44610 | Int Charges | 523,026.80 |
| Jan 15, 2022 | IDA-44610 | Loan Repay | 32,617.04 |
| Jul 15, 2022 | IDA-44610 | Int Charges | 6,268.48 |
| Jul 15, 2022 | IDA-44610 | Int Charges | 6,268.48 |
| Jul 15, 2022 | IDA-44610 | Loan Repay | 13,782.78 |
| Jul 15, 2022 | IDA-44610 | Loan Repay | 4,943,899.00 |
| Jul 15, 2022 | IDA-44610 | Int Charges | 483,373.97 |
| Jul 15, 2022 | IDA-44610 | Int Charges | 483,373.97 |
| Jul 15, 2021 | IDA-44610 | Loan Repay | 2,697,075.00 |
| Jul 15, 2021 | IDA-44610 | Int Charges | 546,157.60 |
| Jul 15, 2021 | IDA-44610 | Int Charges | 546,157.60 |
| Jul 15, 2021 | IDA-44610 | Int Charges | 47,531.71 |
| Dec 24, 2013 | IDA-44610 | Loan Disb | -5,000,000.00 |
| Dec 3, 2013 | IDA-44610 | Loan Cancel | 96,491,504.00 |
| Jul 31, 2013 | IDA-44610 | Loan Disb | 1,925,070.50 |
| Jul 15, 2013 | IDA-44610 | Int Charges | 7,377.79 |
| Jul 15, 2013 | IDA-44610 | Int Charges | 7,377.79 |
| Jul 15, 2013 | IDA-44610 | Int Charges | 818,732.40 |
| Jul 15, 2013 | IDA-44610 | Int Charges | 818,732.40 |
| Jul 15, 2014 | IDA-44610 | Int Charges | 4,261.35 |
| Jul 15, 2014 | IDA-44610 | Int Charges | 4,261.35 |
| Jul 15, 2014 | IDA-44610 | Loan Repay | 5,850,383.50 |
| May 12, 2014 | IDA-44610 | Loan Disb | 1,343,870.80 |
| Jan 15, 2014 | IDA-44610 | Int Charges | 872,361.40 |
| Jan 15, 2014 | IDA-44610 | Int Charges | 872,361.40 |
| Nov 18, 2013 | IDA-44610 | Loan Disb | 2,265,557.50 |
| Jan 15, 2014 | IDA-44610 | Int Charges | 4,823.23 |
| Jan 15, 2014 | IDA-44610 | Int Charges | 4,823.23 |
| Dec 24, 2013 | IDA-44610 | Loan Cancel | 3,666,399.80 |
| Jan 15, 2016 | IDA-44610 | Loan Repay | 5,159,364.00 |
| Jul 15, 2015 | IDA-44610 | Loan Repay | 5,133,106.00 |
| Jul 15, 2015 | IDA-44610 | Int Charges | 754,119.44 |
| Jul 15, 2015 | IDA-44610 | Int Charges | 754,119.44 |
| Jul 15, 2015 | IDA-44610 | Loan Repay | 158,960.12 |
| Jan 15, 2015 | IDA-44610 | Loan Repay | 5,405,358.00 |
| Jan 15, 2015 | IDA-44610 | Int Charges | 790,533.60 |
| Jan 15, 2015 | IDA-44610 | Int Charges | 790,533.60 |
| Jan 15, 2015 | IDA-44610 | Int Charges | 10,944.78 |
| Jan 15, 2015 | IDA-44610 | Int Charges | 10,944.78 |
| Jul 15, 2014 | IDA-44610 | Int Charges | 862,442.40 |
| Jul 15, 2014 | IDA-44610 | Int Charges | 862,442.40 |
| Jul 15, 2016 | IDA-44610 | Loan Repay | 5,275,771.00 |
| Jul 15, 2016 | IDA-44610 | Loan Repay | 2,285.28 |
| Jul 15, 2016 | IDA-44610 | Int Charges | 712,537.60 |
| Jul 15, 2016 | IDA-44610 | Int Charges | 712,537.60 |
| Jan 15, 2016 | IDA-44610 | Int Charges | 726,882.20 |
| Jan 15, 2016 | IDA-44610 | Int Charges | 726,882.20 |
| Jan 15, 2016 | IDA-44610 | Loan Repay | 79,426.44 |
| Jul 15, 2017 | IDA-44610 | Loan Repay | 5,212,306.50 |
| Jul 15, 2017 | IDA-44610 | Int Charges | 585,431.75 |
| Jul 15, 2017 | IDA-44610 | Int Charges | 585,431.75 |
| Jul 15, 2017 | IDA-44610 | Loan Repay | 52,686.56 |
| Jan 15, 2017 | IDA-44610 | Loan Repay | 73,275.10 |
| Jan 15, 2017 | IDA-44610 | Loan Repay | 5,043,212.00 |
| Jan 15, 2017 | IDA-44610 | Int Charges | 671,538.94 |
| Jan 15, 2017 | IDA-44610 | Int Charges | 671,538.94 |
| Jul 15, 2019 | IDA-44610 | Int Charges | 579,619.10 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Overall Implementation Progress (IP) | Moderately Unsatisfactory | 2013-12-25 |
| Progress towards achievement of PDO | Moderately Unsatisfactory | 2013-12-25 |
| Project Management | Moderately Unsatisfactory | 2013-12-25 |
| Financial Management | Moderately Unsatisfactory | 2013-12-25 |
| Monitoring and Evaluation | Moderately Unsatisfactory | 2013-12-25 |
| Procurement | Moderately Unsatisfactory | 2013-12-25 |
| Counterpart Funding | Satisfactory | 2013-12-25 |
COMPLETION RATINGS
| INDICATOR | IMPLEMENTATION COMPLETION & RESULTS REPORT: 06-27-2014 |
|---|---|
| Outcomes | Moderately Unsatisfactory |
| Risk to Development Outcome | Negligible |
| Bank Performance | Moderately Unsatisfactory |
| Borrower Performance | Unsatisfactory |
| Government Performance | Moderately Unsatisfactory |
| Implementing Agency | Unsatisfactory |
INDEPENDENT EVALUATION RATINGS
| INDICATOR | ICR REVIEW: 12-03-2014 | PROJECT PERFORMANCE ASSESSMENT REPORT: |
|---|---|---|
| Outcome Rating | Moderately Unsatisfactory | N/a |
| Risk To Development Outcome | Negligible To Low | N/a |
| Bank Performance | Moderately Unsatisfactory | N/a |
| Borrower Performance | Unsatisfactory | N/a |
| Government Performance | Moderately Unsatisfactory | N/a |
| Implementing Agency | Unsatisfactory | N/a |
| Icr Quality | Satisfactory | N/a |
| M&e Quality | Modest | N/a |
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Percentage of fever cases in project districts receiving a malaria test result no later than the day after the first contact Value 0% (The diagnostic tests supported by the Project Not available 70% Date November 29, 2013 December 31, 2013 Comment No further assessments have been made since the previous one in March 2013. More recent LQAS data is likely to become available byproject closure, but the end-line survey is no longer feasible. Percentage of individuals in project areas belonging to eligible Long Lasting Insecticidal Net (LLIN) target population who slept under an LLIN during the previous night Value 0% (The Program has recently approved the policy f Not available 50% Date January 30, 2009 November 29, 2013 December 31, 2013 Comment No further assessments have been made since the previous one in March 2013. More recent LQAS data is likely to become available byproject closure, but the end-line survey is no longer feasible. At least 50% of the sampled blocks which at baseline have not achieved the elimination goal of less than one kala azar case per 10,000 persons, will achieve elimination goal by endline Value 236 blocks in 3 states (Bihar, Jharkhand, West Ben Data currently being collated and analyzed. 50% Date October 31, 2008 November 29, 2013 December 31, 2013 Comment This is a conservative estimate, based on cases reported from each block in 2010. Actual figures are likely to be several timeshigher, but more accurate estimates are not available from any source. The assessment is currently in progress and is expected to be available prior to project closure. At least 80% of the households with eligible children covered during the national and sub-national immunization days in high risk districts Value >80% (Threshold reached) >98% >80% Date January 31, 2008 November 30, 2012 December 31, 2013 Comment *all activities and procurement under this component has been closed. This estimate is based on previous estimates. The goal ofpolio eradication has been achieved. Continuous monitoring and further activities are being carried on by the GoI through their ownfunds.
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Percentage of Rapid Diagnostic Test (RDT) positive cases in project districts receiving Artemisinin-based Combination Therapy (ACT)no less than the day after the first contact Value 0% (District-wide ACT introduction is being done u Not available 70% Date July 31, 2008 November 29, 2013 December 31, 2013 Comment No further assessments have been made since the previous one in March 2013. More recent LQAS data is likely to become available byproject closure, but the end-line survey is no longer feasible. Percentage of designated providers of malaria diagnosis and treatment who have not had an ACT or RDT stockout during last 3 months. Value 0% (ACT and RDK are being introduced under the pro Not available 90% Date July 31, 2008 November 29, 2013 December 31, 2013 Comment No further assessments have been made since the previous one in March 2013. More recent LQAS data is likely to become available byproject closure, but the end-line survey is no longer feasible. Percentage of diagnosed kala azar cases completing the standard treatment as per the national guidelines. Value 55% (Based on preliminary surveys) Data currently being collated and analyzed. 80% Date January 31, 2007 November 29, 2013 December 31, 2013 Comment The assessment is currently in progress and is expected to be available prior to project closure. Percentage of facilities reporting no stock-outs of rapid disgnostic test for kala azar and first line medicines. Value 73% (For first-line medicines) Data currenly being collated and analyzed. 90% Date January 31, 2007 November 29, 2013 December 31, 2013 Comment The assessment is currently in progress and is expected to be available prior to project closure. Percentage of planned additional staff who are in position at central, state and district levels and received induction training. Value 0 Not available. 100% Date January 31, 2007 November 29, 2013 December 31, 2013 Comment Data is currently being collated. Porportion of eligible districts meeting the readiness criteria for each period of implementation. Value 0% (These criteria are being applied under the pro 100% 100% Date July 31, 2008 November 29, 2013 December 31, 2013 Comment Phase 1 districts during 2010 and phase 2 districts during 2012. 124 malaria endemic districts (50 phase 1 and 74 phase 2districts) and 46 kala azar endemic districts were declared ready. The supply of oral polio vaccines for Supplemental Immunization Activities is sustained. Value No stockout No Stock outs No Stock outs Date July 31, 2008 November 29, 2013 December 31, 2013 Comment **all procurement under this component has been closed. This estimate is based on previous estimates. The goal of polioeradication has been achieved. Further procurement is being carried on by the GoI through their own funds . Long-lasting insecticide-treated malaria nets purchased and/or distributed (number) Value 0.00 6179114.00 8350000.00 Date March 6, 2009 November 29, 2013 December 31, 2013 Comment India started distributing the LLINs with this project No further procurements have occurred since the previous period. Total number of LLINS proposed to be purchased under the project Health personnel receiving training (number) Value 0.00 910.00 950.00 Date March 6, 2009 November 29, 2013 December 31, 2013 Comment Based on PIU reports. Staff attrition has been a problem resulting in a decrease in trained staff. Training for newly joinedstaff continues to be carried out. Total number of staff to be trained in new treatment guidelines as well as the induction training for the new staff andinternational fellowships